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Initial experiments were conducted using an in situ rat 
tibialis anterior (TA) muscle preparation to assess the 
influence of dietary antioxidants on muscle contractile 
properties. Adult Sprague-Dawley rats were divided into 
two dietary groups: 1) control diet (Con) and 2) 
supplemented with vitamin E (VE) and a-lipoic acid (a-LA) 
(Antiox). Antiox rats were fed the Con rats’ diet (AIN-
93M) with an additional 10,000 IU VE/kg diet and 1.65 g/kg 
a-LA. After an 8-wk feeding period, no differences existed 
(P > 0.05) between the two dietary groups in maximum 
specific tension before or after a fatigue protocol or in force 
production during the fatigue protocol. However, in 
unfatigued muscle, maximal twitch tension and tetanic 
force production at stimulation frequencies <40 Hz were less 
(P < 0.05) in Antiox animals compared with Con. To inves- 
tigate which antioxidant was responsible for the depressed 
force production, a second experiment was conducted using 
an in vitro rat diaphragm preparation. Varying concentra- 
tions of VE and dihydrolipoic acid, the reduced form of a-LA, 
were added either individually or in combination to baths 
containing diaphragm muscle strips. The results from these 
experiments indicate that high levels of VE depress skeletal 
muscle force production at low stimulation frequencies. 
antioxidants; contraction; redox; oxidation; reactive oxygen 
species 
 
 
 
IT  WAS  RECOGNIZED  OVER  A  DECADE  AGO  that the redox 
status of skeletal muscle fibers is altered by heavy 
exercise (8). Indeed, exercising muscle produces reac- 
tive oxygen species (ROS) such as superoxide anions 
and hydroxyl radicals (10). Furthermore, it is now clear 
that intense muscular contractile activity can result in 
oxidative stress as indicated by altered muscle gluta- 
thione levels and an increase in both protein oxidation 
and lipid peroxidation (2, 8, 15, 26, 32). When proteins 
and lipids become oxidized by ROS, muscle force pro- 
duction is diminished (22). Reducing agents such as 
antioxidants  can  protect  cells  against  ROS-induced 
oxidative stress (21). Theoretically, it follows that in- 
creasing the intracellular levels of antioxidants within 
a muscle cell should provide greater protection against 
these oxidizing agents and reduce fatigue. However, 
Reid et al. (22) have demonstrated that low levels of 
ROS are required for optimum muscle contractile func- 
tion. Specifically, they demonstrated that addition of 
the antioxidant enzymes (i.e., catalase and superoxide 
dismutase) resulted in diminished in vitro muscle con- 
tractile performance in unfatigued muscle. Further, the 
addition of strong synthetic antioxidants such as dithio- 
threitol (3), N-acetylcysteine (NAC) (13), and DMSO (23) 
to an organ bath containing skeletal muscle also results 
in depressed skeletal muscle force production. Combined, 
these studies indicate that administration of synthetic 
antioxidants may negatively impact skeletal muscle con- 
tractile properties in unfatigued muscle. At present, it is 
unknown whether similar effects occur when antioxi- 
dants are consumed in the diet in large quantities; this 
forms the basis for the current experiments. 
Vitamin E (VE) is an important dietary antioxidant 
in biological systems because of its association with the 
cell membrane and its ability to act directly on ROS 
and prevent lipid peroxidation (6). After quenching a 
radical, VE is converted to a radical (chromanoxyl 
form) and loses its antioxidant capacity. Recent re- 
search has focused on the ability of VE to be reduced 
from this chromanoxyl form back to its native state via 
other antioxidants. This regeneration of VE can be 
achieved by dihydrolipoic acid (DHLA), the reduced 
form of a-lipoic acid (a-LA) (12). In addition to its 
ability to recycle VE, a-LA is also a potent antioxidant 
because of its capacity to quench ROS in both the 
aqueous and lipid phases of the cell (19). Indeed, the 
combination of VE and a-LA has been shown to act 
synergistically to protect cells against oxidative dam- 
age such as ischemia-reperfusion injury, neurodegen- 
eration, and cataract formation (19). Hence, we se- 
lected the combination of the antioxidants VE and a-
LA to determine whether these dietary antioxidants 
impact skeletal muscle contractile function. 
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Therefore, the primary purpose of these experiments 
was to determine the effects of dietary supplementa- 
tion with VE and a-LA on skeletal muscle contractile 
function in situ. On the basis of previous studies, we 
hypothesized that consumption of large quantities of 
dietary antioxidants would negatively impact muscle 
force production in unfatigued skeletal muscle. Our 
results supported this hypothesis and revealed that 
supplementation with a-LA and VE resulted in a right 
shift in the muscle force-frequency curve. These find- 
ings prompted a second series of experiments designed 
to elucidate whether this right shift in the force-fre- 
quency curve was due to VE or a-LA alone or to the 
combination of the two antioxidants. To address this 
question, we used the in vitro rat diaphragm prepara- 
tion and investigated the effects of these antioxidants 
both collectively and individually. 
METHODS 
 
In Situ Experiment (Experiment 1) 
Female Sprague-Dawley rats (4 mo old, n 28) were 
divided into 2 dietary groups: 1) control (Con) and 2) supple- 
mented with VE and a-LA (Antiox). Con animals were fed an 
AIN-93M purified diet containing 75 IU/kg diet VE (DL-a- 
tocopheryl acetate). The Antiox animals were fed the AIN- 
93M purified diet with an additional 10,000 IU/kg diet DL-a- 
tocopheryl acetate (Hoffmann-LaRoche, Nutley, NJ) and 1.65 
g/kg a-LA (Asta Medica, Frankfurt, Germany). Animals were 
fed their respective diets for 8 wk before the measurement of 
muscle contractile properties. Diets were professionally pre- 
pared by Harlan Teklad (Madison, WI). To ensure that all 
animals consumed equal amounts of their respective diets, 
animals were pair fed. This was achieved by first pairing 
animals (14 pairs) on the basis of body weight, allocating one 
to each group, and housing them individually. In seven of the 
pairs, the animal in the Con group was given the weight of 
food that the corresponding pair from the Antiox group con- 
sumed the previous day. In the other seven pairs this was 
reversed so that the animal from the Antiox group received 
the weight of food that the corresponding pair from the Con 
group consumed the previous day. Weight gain was equal 
between groups (data not presented). 
On completion of the feeding period, animals were anes- 
thetized with an intraperitoneal injection of pentobarbital 
sodium (40 mg/kg) and ventilated (tidal volume   0.7 ml/100 
g body mass; breathing frequency 80 breaths/min and 
positive end-expiratory pressure 1.0 cmH2O) with room air 
using a Columbus small animal ventilator (CIV-101, Colum- 
bus, OH) to maintain a constant arterial partial pressure of 
to-digital conversion for analysis with a computer-based data 
acquisition system (GW Instruments-Series II, Somerville, 
MA). 
Muscle temperature and moisture were maintained with a 
heating lamp and saline-soaked gauze, respectively. The or- 
igin of the TA muscle was anchored with a bone nail placed in 
the femur perpendicular to the limb. Previous experiments in 
our laboratory indicate that circulation to the muscle was not 
affected by the procedure (unpublished results). Calibration 
of the force transducer was done by applying known weights 
on the lever. The TA was stimulated to contract via stimula- 
tion of the sciatic nerve with a Grass Instruments S48 stim- 
ulator (Quincy, MA). Twitch measurements were used to 
determine optimal muscle length (Lo) initially and through- 
out the experiment. Maximal specific tension (Po), twitch 
tension (Pt), and a force-frequency curve were then deter- 
mined at Lo before and after a 60-min fatigue protocol. 
Po was measured with a series of isometric tetanic contrac- 
tions using a supramaximal stimulus train (250 ms, 60 V, 
and 150 Hz). Each tetanic contraction was separated by a 
2-min recovery period to prevent fatigue between contrac- 
tions. The absolute maximal force was then divided by the 
wet weight of the TA to obtain Po (N/kg). Pt was measured 
with a 2-ms twitch contraction at 60 V. The force-frequency 
curve was determined by stimulating the muscle to contract 
every 2 min at 10, 20, 30, 40, 60, 80, 120, 160, 200, and 250 
Hz (60-V, 250-ms trains). The fatigue protocol consisted of 
60-V, 15-Hz trains every 2 s. The duty cycle [ratio of the 
period of muscle contraction (250 ms) to the duration of a 
cycle of contraction and rest (2,250 ms)] was 1:9. 
Immediately after the contractile measurements, the ani- 
mal was euthanized with a lethal injection of pentobarbital 
sodium (100 mg/kg). The TA muscle was removed, trimmed 
of fat and connective tissue, weighed, frozen in liquid nitro- 
gen, and stored at -80°C for future biochemical analyses. 
The contralateral TA was also removed for comparative bio- 
chemical measurements. 
Measurement of VE levels in muscle. The concentration of 
VE in the TA was determined with high-performance liquid 
chromatography (HPLC) using the protocol of Cort et al. (7). 
Samples from both the contracted and the contralateral limb 
were homogenized in acetone using a mechanical homoge- 
nizer (Ultra-Turrax T25, IKA Works, Cincinnati, OH). Sam- 
ples were extracted twice with petroleum ether and then 
reconstituted in isooctane and analyzed for VE content. The 
isooctane extract (20 µl) was injected onto a 250 x 4 mm, 
10-µm LiChrosorb SI column (Baird and Tatlock, Dagenham, 
UK). 
Measurement of a-LA levels in muscle. Tissue levels of 
a-LA were measured according to Panigrahi et al. (20), with 
slight modification. Frozen samples (0.5–0.6 g) were ground 
to powder in liquid nitrogen with a mortar and pestle then 
O2  (PaO ) of ~90 mmHg. PaO was determined via blood gas homogenized on ice in 2 ml of 20% metaphosphoric acid using 
2 2 
analysis (IL 1610, Instrumentation Laboratories, Lexington, 
MA) with 75-µl samples taken from the arterial catheter. 
Pa was maintained by increasing the respiratory frequency 
2 
when necessary. 
Rectal temperature was monitored, and body temperature 
was maintained at 37°C with a heating blanket. After a 
surgical plane of anesthesia was reached, the sciatic nerve 
was located and cut, with the distal stump placed in a bipolar 
electrode. The tendon of the tibialis anterior (TA) muscle was 
cut close to the bone and attached to an isotonic force trans- 
ducer (Piezo Systems, Cambridge, MA, model 400). The TA 
was chosen for the experiment because of its mixed-fiber-type 
composition. The transducer output was amplified and dif- 
ferentiated by operational amplifiers and underwent analog- 
a Teflon homogenizer. The homogenate was ultrasonicated 
intermittently for 100 s (10-s periods with 10 s rest). After 
hexane evaporation under nitrogen, the extract was solubi- 
lized in a solvent containing 50% 0.2 M monochloroacetic 
acid, 30% acetonitrile, and 20% methanol. Samples were 
filtered (0.22 µm) and frozen at -80°C for HPLC analysis. 
Samples (0.2 ml) were separated on a Alltima C18 column 
(250 x 4.6 mm, 5 µm; Alltech Associates, Deerfield, IL) using 
a mobile phase consisting of 50% 50 mM sodium biphosphate 
in water, 30% acetonitrile, and 20% methanol and a flow rate 
of 1 ml/min. a-LA was detected at a retention time of 9.5 min 
using a Coulechem II multielectrode electrochemical detector 
(ESA model 5100A, ESA, Chelmsford, MA). The electrodes 
were set at the following potentials: electrode 1, +0.45 V; 
 
 
electrode 2, +0.85 V; and guard cell: +0.90 V. Racemate 
mixture of lipoate (50% DHLA, 50% a-LA), used as a stan- 
dard, was provided by ASTA Medica (Frankfurt, Germany). 
With the use of this method, a linear (r2 0.996) standard 
curve in the range 0.2–0.75 nM of lipoate was obtained. 
Lipid peroxidation measurements. To determine the 
amount of oxidative damage in the TA, levels of lipid peroxi- 
dation were measured by two methods. First, malondialde- 
hyde levels were measured spectrophotometrically using the 
thiobarbituric acid-reactive substance (TBARS) method de- 
scribed by Mihara and Uchiyama (16). 1,1,3,3-Tetra- 
ethoxypropane was used as the standard for this assay. 
Secondly, lipid hydroperoxides were quantified using the 
ferrous oxidation/xylenol orange technique described by 
Hermes-Lima et al. (11). Cumene hydroperoxide was used as 
the standard for this assay, and hydroperoxide values are 
expressed in cumene hydroperoxide equivalents (CHE). In 
our hands, the coefficients of variation for the TBARS and the 
lipid hydroperoxide assays are ~3 and 4%, respectively. 
In Vitro Protocol (Experiment 2) 
The TA muscle was not used in our in vitro experiments 
because the diameter of this muscle is too great to permit 
gases to diffuse to and from deep fibers in a nonperfused in 
vitro preparation. Hence, to avoid this problem, we selected 
the costal diaphragm for study because the diameter of this 
muscle in the rat  is not  diffusion limited in an in vitro 
preparation. Similar to the TA, the costal diaphragm is a 
mixed-fiber muscle. Importantly, the in vitro rat diaphragm 
preparation is a well-established model to study skeletal 
muscle function in vitro (9, 10, 13, 21–23). 
Four-month-old female Sprague-Dawley rats (n 32) were 
anesthetized with an intraperitoneal injection of pentobarbi- 
tal sodium (90 mg/kg). When the animal reached a surgical 
plane of anesthesia, the diaphragm was quickly excised with 
the ribs and central tendon intact and placed in Krebs-Ringer 
solution (containing in mM: 137 NaCl, 5 KCl, 2 CaCl, 1 
MgSO4, 1 NaH2PO4, and 24 NaHCO3) equilibrated with 95% 
O2-5% CO2 (pH 7.4). Two small strips of muscle (~3.0 x 
20–25 mm) from the ventral costal diaphragm were carefully 
cut with a portion of rib and central tendon retained on each 
strip to enable the attachment of a clamp without compro- 
mising constituent fibers. 
Figure 1 illustrates the protocol of experiment 2. Isometric 
contractile properties of each strip were measured simulta- 
neously using a dual-bath setup. Each muscle strip was 
suspended vertically between two lightweight Plexiglas 
clamps in a 100-ml temperature-controlled bath (Harvard 
Scientific, Holliston, MA). Each strip was connected to an 
isometric force transducer (Grass FT-03D) and mounted on a 
micrometer for adjustment of muscle length. The baths con- 
tained Krebs-Ringer solution with 25 µM D-tubocurarine 
chloride and equilibrated with 95% O2-5% CO2. Field stimu- 
lation was created along the entire length of each muscle 
strip with platinum plate electrodes (4 x 37 mm) using a 
modified Grass Instruments S48 stimulator (Quincy, MA). 
The stimulator was modified to produce sufficient amperage 
for field stimulation in both baths simultaneously. Output 
from each transducer was amplified and differentiated by 
operational amplifiers and underwent analog-to-digital con- 
version for analysis using a computer-based data acquisition 
system (GW Instruments-Series II). 
At the beginning of each protocol, the strips were main- 
tained at 25°C to minimize temperature-dependent deterio- 
ration. Each strip was adjusted to its Lo by systematically 
altering the length of the muscle using a micrometer while 
evoking twitch contractions (140 V, 2-ms duration). Once Lo 
was established, Po was measured using tetanic contractions 
(100 Hz, 330 ms, 140 V). Maximal force generation during 
tetanic contractions was normalized to cross-sectional area 
(CSA) and expressed as newtons (N/cm2). CSA was estimated 
using the formula CSA (cm2) muscle mass (g)/[muscle 
length (cm) x muscle density (g/cm3)], assuming muscle 
density 1.056 g/cm3 (30). Response of the diaphragm mus- 
cle strip to increasing stimulus frequency was assessed at Lo, 
by the application of 20-, 30-, 40-, 60-, 80-, 120-, 160-, and 
200-Hz pulses applied in 330-ms trains at 140 V. A 2-min 
recovery period was used between contractions. At the com- 
pletion of the force-frequency protocol, the temperature of the 
muscle bath was increased to 37°C, and either an antioxidant 
treatment or the vehicle (alcohol) was added to the muscle 
baths. The following antioxidant treatments were investi- 
gated: 1) combination of VE (400 µM) and DHLA (100 µM), 2) 
VE (400 µM), 3) DHLA (100 µM), 4) VE (200 µM), or 5) VE 
(100 µM). Each experimental treatment was prepared by 
adding the compound(s) to 500 µl of alcohol and vortexing in 
an Eppendorf tube until dissolved. Thirty minutes after the 
increase in bath temperature and the addition of the afore- 
mentioned compound(s) to the baths, Po, Pt, and the force- 
frequency relationship were assessed. Note that alcohol did 
not affect contractile properties of the muscle strip in the 
control bath. 
Fatigue of the diaphragm strips was then determined by 
monitoring the decrease in force development over time. The 
muscle strips were stimulated simultaneously with tetanic 
contractions (40 Hz, 250 ms) every 2 s (duty cycle 1:9). This 
pattern of stimulation was chosen to elicit a 40–50% reduc- 
tion in force in 30 min. Fatigue was determined at 37°C 
because Diaz et al. (9) have shown that antioxidants are more 
likely to have an effect on diaphragm fatigue resistance in 
vitro at this temperature. 
Data Analysis 
Comparisons between groups for each dependent variable 
were made using either a one-way or two-way (repeated- 
measures) ANOVA where appropriate. For multiple compar- 
isons, a Bonferroni correction was used. Differences were 
evaluated via post hoc analysis using a Scheffé’s test. Signif- 
icance was established a priori at P < 0.05. 
 
RESULTS 
Experiment 1 
Supplementation with VE and a-LA resulted in a 
significant increase (P < 0.05) in the VE and lipoate 
content of the tibialis anterior (TA) (Fig. 2). In addi- 
tion, the contractile protocol was associated with a 
significant loss (P < 0.05) of VE from the stimulated 
muscle only in supplemented animals. 
 
Fig. 1. Schematic illustration of the 
protocol used in experiment 2. Lo, opti- 
mal muscle length; Po, maximal spe- 
cific tension; Pt, maximal twitch ten- 
sion. 
 
 
 
 
Fig. 2. Vitamin E (top) and a-lipoic acid (bottom) concentrations 
from the tibialis anterior of rats fed either a control diet (Con; n 14) 
or a diet supplemented with vitamin E and a-lipoic acid (Antiox; n 
14). Values are means ± SE. *Significantly different from control 
diet animal (P < 0.05); **significantly different from contralateral 
muscle using 1-way ANOVA (P < 0.05). 
 
Fig. 3. Force-frequency curves for tibialis anterior of Con (n   11) 
or Antiox rats (n   12) measured before (top) and after (bottom) a 
fatigue protocol (P < 0.05). Values are means ± SE. *Signifi 
different from Antiox using multiple t-tests with Bonferroni cor- 
rection (P < 0.001). 
 
A comparison of the contractile properties of the TA 
from Con and Antiox animals before the fatigue proto- 
col is presented in Table 1. Supplementation with VE 
and a-LA had no significant effect (P > 0.05) on Po and 
the tetanic-twitch ratio (Po/Pt). There was, however, a 
significant decrease (P < 0.05) in Pt in supplemented 
animals. 
Figure 3 illustrates the force-frequency response be- 
fore and after the fatigue protocol. Before the fatigue 
protocol, muscle force production was significantly de- 
pressed (P < 0.05) at stimulation frequencies < 40 Hz 
in Antiox animals. However, after the fatigue protocol, 
no group differences existed (P > 0.05) in force produc- 
tion at any stimulation frequency. 
No differences existed (P > 0.05) in TA force produc- 
tion between Con and Antiox animals throughout the 
60-min fatigue protocol (Fig. 4). Furthermore, no dif- 
ferences existed (P > 0.05) between groups in muscle 
contractile properties after the fatigue protocol (data 
not shown). 
 
Table 1. Contractile measurements from the tibialis 
anterior of rats fed either a control diet or a diet 
supplemented with vitamin E and a-lipoic acid 
 
 
 
 
Values are means ± SE; n, no. of rats per group. Po, maximal 
tetanic tension; Pt, maximal twitch tension; Po/Pt,  tetanic-twitch 
ratio; Con, rats fed control diet; Antiox, rats fed a diet supplemented 
with vitamin E and a-lipoic acid. * Significantly different from con- 
trol using a 1-way ANOVA (P < 0.05). 
Two markers of lipid peroxidation were used to 
determine the effects of the contractile protocol on 
oxidative damage of the TA in experiment 1. Figure 5 
contains the values for TBARS and CHE in both 
experimental groups. Similar results were obtained 
by using the two markers of lipid peroxidation. In the 
Con diet group, the contractile protocol resulted in a 
signifi  increase (P < 0.05) in both TBARS and 
CHE levels in the stimulated TA compared with the 
contralateral muscle. An important fi was that 
the stimulated TA from the Antiox animals had 
signifi lower (P < 0.05) TBARS and CHE levels 
compared with the contracted TA from Con animals. 
Experiment 2 
Table 2 shows the initial contractile measurements 
from the rat diaphragm in vitro experiment. Addition 
 
 
Fig. 4. Average force production of the tibialis anterior undergoing a 
60-min fatigue protocol from Con (n 11) or Antiox rats (n 12). 
Values are means ± SE. No differences between group means at any 
time point using 2-way repeated-measures ANOVA with Bonferroni 
correction (P > 0.001). 
 n Po, N/kg Pt, N/kg Po/Pt 
Con 11 1.98 ± 0.06 0.72 ± 0.03 2.8 ± 0.1 
Antiox 12 1.83 ± 0.06 0.58 ± 0.04* 3.2 ± 0.2 
 
 
  
 
 
Fig. 6. Comparison of the force-frequency curves for diaphragm 
strips incubated in either 1) the dissolving medium (control, n     5); 
2) vitamin E (Vit E; 400 µM, n 6); or 3) Vit E (400 µM) and 
dihydrolipoic acid (DHLA; 100 µM, n 6). Values are means ± SE. 
Strips incubated in either 400 µM or the combination of 400 µM Vit 
E and 100 µM DHLA produced less force at frequencies <40 Hz 
using 1-way ANOVA with Bonferroni correction (P < 0.001). 
 
 
 
Fig. 5. Thiobarbituric acid-reactive substance (TBARS; top) and 
cumene hydroperoxide equivalent (CHE; bottom) concentrations in 
the tibialis anterior of Con (n  11) or Antiox rats (n   12). Values 
are means ± SE. *Significantly different from contralateral muscle 
(Con); **significantly different from Con animal (stimulated) using 
1-way ANOVA (P < 0.05). 
 
 
of VE and DHLA to the preparation did not impact 
(P > 0.05) Po  or Po/Pt. 
Similar to the in situ experiment, there was a signif- 
icant decrease (P < 0.05) in Pt and maximal force 
production at frequencies <40 Hz when either the 
combination of VE (400 µM) and DHLA (100 µM) or VE 
(400 µM) was added to the bath (Fig. 6). Compared 
with control, no differences existed in the force-fre- 
quency relationship when either DHLA (100 µM), VE 
(200 µM) or VE (100 µM) was added to the bath (data 
not shown). 
Finally, there were no differences in (in vitro) muscle 
fatigue between control and any of the antioxidant 
treatments. Figure 7 shows data comparing control 
with the combination of VE (400 µM) and DHLA (100 
µM). The data for the other treatments are not shown. 
 
 
Table 2. Contractile measurements from experiment 2 
 
 
 
 
 
 
(100 µM) 6 26.5 ± 1.1 4.9 ± 0.7* 5.4 ± 0.7* 
DISCUSSION 
Summary of Principal Findings 
To our knowledge, this is the first study to examine 
the effects of dietary supplementation of dietary anti- 
oxidants on skeletal muscle contractile function in situ. 
Our results indicate that 8 wk of supplementation with 
VE and a-LA significantly increased the levels of these 
antioxidants within the TA muscle. Interestingly, al- 
though dietary supplementation with antioxidants re- 
duced the magnitude of contraction-induced lipid per- 
oxidation in the TA muscle, antioxidant supplementa- 
tion did not improve the fatigue resistance of this 
muscle during an in situ fatigue protocol. Furthermore, 
in nonfatigued muscle, the TA from antioxidant-sup- 
plemented animals generated less tetanic force at stim- 
ulation frequencies <40 Hz. On the basis of this result, 
we performed a second series of experiments using an 
in vitro rat diaphragm preparation to determine which 
antioxidant was responsible for this loss of contractile 
force. When muscle strips were incubated in either 400 
µM of VE alone or a combination of VE (400 µM) and 
DHLA (100 µM), a reduction in submaximal tetanic 
 
 
 
Fig. 7. Average force production of diaphragm strips during a fa- 
tigue protocol. Strips were incubated in either 400 µM Vit E and 100 
  µM DHLA (n     6) or the dissolving medium (n     5) during a fatigue 
Values are means ± SE; n, no. of rats per group. Vit E, vitamin E; 
DHLA, dihydrolipoic acid. * Significantly different from control using 
a 1-way ANOVA (P < 0.05). 
protocol. Values are means ± SE. No differences were found between 
group means at any time point using 2-way repeated-measures 
ANOVA with Bonferroni correction (P > 0.001). 
 n Po, N/cm2 Pt, N/cm2 Po/Pt 
Control 5 27.2 ± 0.8 6.8 ± 0.4 4.0 ± 0.6 
Vit E (100 µM) 5 27.1 ± 1.2 6.7 ± 0.4 4.0 ± 0.3 
Vit E (200 µM) 5 27.4 ± 0.9 5.7 ± 0.5 4.8 ± 0.6 
Vit E (400 µM) 6 26.9 ± 1.3 5.1 ± 0.6* 5.3 ± 0.7* 
DHLA (100 µM) 5 27.2 ± 1.2 6.5 ± 0.8 4.2 ± 0.7 
Vit E (400 µM)/DHLA     
 
 
 
force generation was observed (i.e., right shift in the 
force-frequency relationship). However, incubation 
with DHLA alone (up to 100 µM) or low levels of VE 
alone (<200 µM) did not alter the normal force-fre- 
quency relationship. Collectively, these results indi- 
cate that dietary supplementation with high doses of 
VE can result in a depression in muscle contractile 
function at low stimulation frequencies. 
 
Dietary Antioxidants and Muscle Force Production 
Again, our results indicate that dietary consumption 
of high doses of antioxidants impairs muscle force 
production in situ. This finding supports previous in 
vitro studies indicating that exogenous antioxidants 
have a negative effect on skeletal muscle contractile 
function in unfatigued muscle (9, 13, 22, 23, 25). For 
example, Reid et al. (22) demonstrated that isolated 
diaphragm fiber bundles incubated with the antioxi- 
dant enzymes catalase and superoxide dismutase dis- 
play depressed submaximal tetanic contractile force 
generation. Similarly, investigators have demon- 
strated that incubation of skeletal muscle with NAC 
resulted in a depression of submaximal tetanic force 
production (9, 13). Collectively, the current in situ data 
and previously published in vivo results indicate that 
high levels of antioxidants can negatively effect both 
twitch and submaximal tetanic contractions in unfa- 
tigued muscle. Collectively, these observations support 
the notion that a redox balance must exist for optimal 
skeletal muscle contractile function. 
How does redox balance influence muscle force pro- 
duction? The literature indicates that several redox- 
sensitive skeletal muscle proteins play active roles in 
the contractile process. For example, the ryanodine- 
sensitive calcium release channel of the sarcoplasmic 
reticulum (SR) has multiple sulfhydryl groups that are 
sensitive to redox modulation by ROS or reactive ni- 
trogen species (1, 24). We postulate that in the present 
study the antioxidant supplementation led to an in- 
creased antioxidant concentration in the SR mem- 
branes, leading to a reduction of regulatory sulfhydryls 
on the calcium release channel. This would result in a 
redox depression of calcium transients during twitch 
and low-frequency tetanic stimulation, leading to lower 
muscle force production. Nonetheless, based on the 
present data alone, this postulate is conjecture because 
it is not possible to determine the exact redox mecha- 
nism(s) responsible for the impaired muscle force pro- 
duction at low stimulation frequencies. This is an in- 
teresting area for future research. 
Combined, these data indicate that optimal contrac- 
tile function depends on the redox state of some or all 
of the cellular elements that participate in muscular 
contraction. The present study did not determine the 
VE content of organelles such as the SR. Nonetheless, 
given the lipid composition of the SR, it seems likely 
that both the in vivo supplementation and the in vitro 
incubation resulted in additional VE availability at the 
SR membrane; this could have modified redox balance 
and impacted contractile function. Additional studies 
are required to determine the molecular mechanisms 
responsible for the VE interference with muscle force 
production during submaximal tetanic stimulation. 
The observation that dietary supplementation of di- 
etary antioxidants in rats is capable of interfering with 
skeletal muscle contractile function at low stimulation 
frequencies may have implications to humans consum- 
ing megadoses of antioxidants. Indeed, the dietary 
levels of VE provided to animals in the current exper- 
iments results in blood levels of VE in the rat that are 
comparable to blood VE levels in humans taking VE 
doses of 1,000 IU/day (91 ± 6 µm) (29). Nonetheless, 
whether or not dietary supplementation with high 
doses of VE would impair human muscle performance 
is unknown; this is an interesting area for further 
research. 
Dietary Antioxidants and Muscle Fatigue 
A number of studies have reported that exogenous 
antioxidants protect against skeletal muscle fatigue (4, 
9, 13, 14, 18, 23, 28, 31). Most of these studies have 
applied synthetic or enzymatic antioxidants and em- 
ployed in vitro muscle preparations (4, 9, 13, 23, 28, 
31). For example, NAC has been shown to reduce 
fatigue in both rabbit (28) and rat diaphragms (9, 13). 
Further, Barclay and Hansel (4) used DMSO to dem- 
onstrate that skeletal muscle fatigue can be attenuated 
with antioxidant administration in both an in vitro 
mouse soleus model and an in situ canine gastrocne- 
mius-plantaris preparation. These authors concluded 
that oxidative stress contributes to muscular fatigue. 
Although dietary antioxidant supplementation at- 
tenuated exercise-induced lipid peroxidation in the TA 
muscle in our experiments, our data indicate that nei- 
ther the in situ nor in vitro models of muscular fatigue 
were affected by antioxidant administration. This ob- 
servation agrees with a number of studies investigat- 
ing the ergogenic potential of dietary supplementation 
with antioxidants. In this regard, three studies have 
concluded that dietary antioxidants do not improve 
muscular performance (5, 17, 27). However, a recent 
study has reported a performance benefit of antioxi- 
dants. Specifically, Lands et al. (14) used a cysteine 
donor to augment endogenous glutathione synthesis 
and reported an improvement in human exercise tol- 
erance during short-duration leg exercise (i.e., isoki- 
netic cycling). Additional research to corroborate these 
findings at varying exercise intensities and durations 
is warranted. 
Summary and Conclusions 
The purpose of these experiments was to determine 
the effects of the dietary antioxidants VE and a-LA on 
skeletal muscle contractile function. Our experiments 
demonstrate that dietary supplementation with VE 
and a-LA results in a right shift in the muscle force- 
frequency relationship. Subsequent experiments using 
the rat in vitro diaphragm model revealed that the 
depressed contractility of skeletal muscle at low stim- 
ulation frequencies was due to the effects of VE. Re- 
 
  
 
sults from both experiments indicated that these anti- 
oxidant supplements had no effect on skeletal muscle 
fatigue. We conclude from these observations that the 
dietary antioxidant VE, in high doses, has a negative 
effect on skeletal muscle function. 
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Hä nninen O. Fish oil and vitamin E supplementation in oxida- 
tive stress at rest and after physical exercise. J Appl Physiol 83: 
189–195, 1997. 
27. Sharman IM, Down MG, and Sen RN. The effects of vitamin 
E and training on physiological function and athletic perfor- 
mance in adolescent swimmers. Br J Nutr 26: 265–276, 1971. 
28. Shindoh C, DiMarco A, Thomas A, Manubay P, and Supin- 
ski G. Effect of N-acetylcysteine on diaphragm fatigue. J Appl 
Physiol 68: 2107–2113, 1990. 
29. Simons LA, von Konigsmark M, Simons J, Stocker R, and 
Celermajer DS. Vitamin E ingestion does not improve arterial 
endothelial dysfunction in older adults. Atherosclerosis 143: 
193–199, 1999. 
30. Taylor JA and Kandarian SC. Advantage of normalizing force 
production to myofibrillar protein in skeletal muscle cross-sec- 
tional area. J Appl Physiol 76: 974–978, 1994. 
31. Travaline JM, Sudarshan S, Roy BG, Cordova F, Leyenson 
V, and Criner GJ. Effect of N-acetylcysteine on human dia- 
phragm strength and fatigability. Am J Respir Crit Care Med 
156: 1567–1571, 1997. 
32. Witt EH, Reznick AZ, Viguie CA, Starke-Reed P, and 
Packer L. Exercise, oxidative damage and effects of antioxidant 
manipulation. J Nutr 122: 766–773, 1992. 
